Not logged in Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1 Tran, Thuy T.; Sanchez-Zuno, Gabriela Athziri; Osmani, Lais; Caulfield, Jasmine; Valdez, Caroline Naomi; Piecychna, Marta; Leng, Lin; Armstrong, Michelle E.; Donnelly, Seamas C.; Bifulco, Carlo B.; Clister, Terri; Kulkarni, Rajan P.; Zhang, Lin; Sznol, Mario; Jilaveanu, Lucia; Kluger, Harriet M.; Kang, Insoo; Bucala, Richard Share Save
Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction Li, Xinxing; Liu, Tao; Bacchiocchi, Antonella; Li, Mengxing; Cheng, Wen; Wittkop, Tobias; Mendez, Fernando L.; Wang, Yingyu; Tang, Paul; Yao, Qianqian; Bosenberg, Marcus W.; Sznol, Mario; Yan, Qin; Faham, Malek; Weng, Li; Halaban, Ruth; Jin, Hai; Hu, Zhiqian Share Save
Prospective analysis of pretreatment circulating CD4 memory T cell features associated with severe immunotherapy toxicity Usmani, Abul; Earland, Noah; Zhang, Wubing; Harris, Peter K.; Bacchiocchi, Antonietta; Sachs, Chloe M.; Nene, Aishwarya; Chen, David Y.; Sznol, Mario; Halaban, Ruth; Newman, Aaron M.; Chaudhuri, Aadel A. Share Save
Immunotherapy utilization in stage IIIA melanoma: less may be more Frey, Alexander E.; Kerekes, Daniel M.; Khan, Sajid A.; Tran, Thuy T.; Kluger, Harriet M.; Clune, James E.; Ariyan, Stephan; Sznol, Mario; Ishizuka, Jeffrey J.; Olino, Kelly L. Share Save
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better Djureinovic, Dijana; Weiss, Sarah A.; Krykbaeva, Irina; Qu, Rihao; Vathiotis, Ioannis; Moutafi, Myrto; Zhang, Lin; Perdigoto, Ana L.; Wei, Wei; Anderson, Gail; Damsky, William; Hurwitz, Michael; Johnson, Barbara; Schoenfeld, David; Mahajan, Amit; Hsu, Frank; Miller-Jensen, Kathryn; Kluger, Yuval; Sznol, Mario; Kaech, Susan M.; Bosenberg, Marcus; Jilaveanu, Lucia B.; Kluger, Harriet M. Share Save
Determinants of overall survival in patients with metastatic uveal melanoma Demkowicz, Patrick; Pointdujour-Lim, Renelle; Miguez, Sofia; Lee, Yesung; Jones, Bailey S. C. L.; Barker, Christopher A.; Bosenberg, Marcus; Abramson, David H.; Shoushtari, Alexander N.; Kluger, Harriet; Francis, Jasmine H.; Sznol, Mario; Bakhoum, Mathieu F. Share Save
Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma Miguez, Sofia; Lee, Ryan Y.; Chan, Alison X.; Demkowicz, Patrick C.; Jones, Bailey S. C. L.; Long, Christopher P.; Abramson, David H.; Bosenberg, Marcus; Sznol, Mario; Kluger, Harriet; Goldbaum, Michael H.; Francis, Jasmine H.; Pointdujour-Lim, Renelle; Bakhoum, Mathieu F. Share Save
GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors Luke, Jason J.; Johnson, Melissa; Tolcher, Anthony; Chen, Christopher T.; Dai, Tong; Curti, Brendan D.; El-Khoueiry, Anthony; Sznol, Mario; Henick, Brian S.; Horak, Christine; Jayaraman, Pushpa; Cole, Christopher B.; Wilson, Dawn; Cao, Lizhi; Peng, Li; Feltquate, David; Lathers, Deanne; Sharma, Manish R. Share Save
Association between circulating CD4 memory T cell levels and severe immune-related adverse events in melanoma patients treated with immune checkpoint blockade Usmani, Abul; Earland, Noah; Zhang, Wubing; Harris, Peter K.; Bacchiocchi, Antonietta; Nene, Aishwarya; Chen, David Y.; Sznol, Mario; Halaban, Ruth; Newman, Aaron M.; Chaudhuri, Aadel A. Share Save
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better Djureinovic, Dijana; Weiss, Sarah A.; Krykbaeva, Irina; Qu, Rihao; Vathiotis, Ioannis; Moutafi, Myrto; Zhang, Lin; Perdigoto, Ana L.; Wei, Wei; Anderson, Gail; Damsky, William; Hurwitz, Michael; Johnson, Barbara; Mahajan, Amit; Hsu, Frank; Miller-Jensen, Kathryn; Kluger, Yuval; Sznol, Mario; Kaech, Susan M.; Bosenberg, Marcus; Jilaveanu, Lucia; Kluger, Harriet M. Share Save
Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02 Siefker-Radtke, Arlene O.; Cho, Daniel C.; Diab, Adi; Sznol, Mario; Bilen, Mehmet A.; Balar, Arjun, V; Grignani, Giovanni; Puente, Erika; Tang, Lily; Chien, David; Hoch, Ute; Choudhury, Arkopal; Yu, Danni; Currie, Sue L.; Tagliaferri, Mary A.; Zalevsky, Jonathan; Hurwitz, Michael E.; Tannir, Nizar M. Share Save
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC) Atkins, Michael B.; Abu-Sbeih, Hamzah; Ascierto, Paolo A.; Bishop, Michael R.; Chen, Daniel S.; Dhodapkar, Madhav; Emens, Leisha A.; Ernstoff, Marc S.; Ferris, Robert L.; Greten, Tim F.; Gulley, James L.; Herbst, Roy S.; Humphrey, Rachel W.; Larkin, James; Margolin, Kim A.; Mazzarella, Luca; Ramalingam, Suresh S.; Regan, Meredith M.; Rini, Brian, I; Sznol, Mario Share Save
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors Sanborn, Rachel E.; Pishvaian, Michael J.; Callahan, Margaret K.; Weise, Amy; Sikic, Branimir, I; Rahma, Osama; Cho, Daniel C.; Rizvi, Naiyer A.; Sznol, Mario; Lutzky, Jose; Bauman, Julie E.; Bitting, Rhonda L.; Starodub, Alexander; Jimeno, Antonio; Reardon, David A.; Kaley, Thomas; Iwamoto, Fabio; Baehring, Joachim M.; Subramaniam, Deepa S.; Aragon-Ching, Jeanny B.; Hawthorne, Thomas R.; Rawls, Tracey; Yellin, Michael; Keler, Tibor Share Save
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma Oria, Victor O.; Zhang, Hongyi; Zito, Christopher R.; Rane, Chetan K.; Ma, Xian-Yong; Provance, Olivia K.; Tran, Thuy T.; Adeniran, Adebowale; Kluger, Yuval; Sznol, Mario; Bosenberg, Marcus W.; Kluger, Harriet M.; Jilaveanu, Lucia B. Share Save
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors Kim, Tae Won; Burris, Howard A.; Luken, Maria J. de Miguel; Pishvaian, Michael J.; Bang, Yung-Jue; Gordon, Michael; Awada, Ahmad; Camidge, D. Ross; Hodi, F. Stephen; McArthur, Grant A.; Miller, Wilson H., Jr.; Cervantes, Andres; Chow, Laura Q.; Lesokhin, Alexander M.; Rutten, Annemie; Sznol, Mario; Rishipathak, Deepali; Chen, Shang-Chiung; Stefanich, Eric; Pourmohamad, Tony; Anderson, Maria; Kim, Jeong; Huseni, Mahrukh; Rhee, Ina; Siu, Lillian L. Share Save
Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function Jessel, Shlomit; Weiss, Sarah A.; Austin, Matthew; Mahajan, Amit; Etts, Katrina; Zhang, Lin; Aizenbud, Lilach; Perdigoto, Ana Luisa; Hurwitz, Michael; Sznol, Mario; Herold, Kevan C.; Kluger, Harriet M. Share Save
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006 Long, G. V.; Arance, A.; Mortier, L.; Lorigan, P.; Blank, C.; Mohr, P.; Schachter, J.; Grob, J. -J.; Lotem, M.; Middleton, M. R.; Neyns, B.; Steven, N.; Ribas, A.; Walpole, E.; Carlino, M. S.; Lebbe, C.; Sznol, M.; Jensen, E.; Leiby, M. A.; Ibrahim, N.; Robert, C. Share Save
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma Lozano, Alexander X.; Chaudhuri, Aadel A.; Nene, Aishwarya; Bacchiocchi, Antonietta; Earland, Noah; Vesely, Matthew D.; Usmani, Abul; Turner, Brandon E.; Steen, Chloe B.; Luca, Bogdan A.; Badri, Ti; Gulati, Gunsagar S.; Vahid, Milad R.; Khameneh, Farnaz; Harris, Peter K.; Chen, David Y.; Dhodapkar, Kavita; Sznol, Mario; Halaban, Ruth; Newman, Aaron M. Share Save
Share Save
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1 Weiss, Sarah A.; Djureinovic, Dijana; Jessel, Shlomit; Krykbaeva, Irina; Zhang, Lin; Jilaveanu, Lucia; Ralabate, Amanda; Johnson, Barbara; Levit, Neta Shanwetter; Anderson, Gail; Zelterman, Daniel; Wei, Wei; Mahajan, Amit; Trifan, Ovid; Bosenberg, Marcus; Kaech, Susan M.; Perry, Curtis J.; Damsky, William; Gettinger, Scott; Sznol, Mario; Hurwitz, Michael; Kluger, Harriet M. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
